The FDA has approved Boston Scientific’s Emblem MRI Subcutaneous Implantable Defibrillator (S-ICD) system. This milestone comes on the heels of Boston Scientific receiving MR conditional labeling for its previously implanted Emblem S-ICD Systems.
The latest addition to its line of ImageReady MR-conditional devices, the new Emblem MRI S-ICD system allows patients to experience MRI safely. A proven treatment option for patients at risk of sudden cardiac arrest, the system leaves the heart and vasculature untouched—and that reduces the risk of complications associated with conventional transvenous implantable cardioverter-defibrillator leads.
“Now with FDA approval, patients receiving the Emblem MRI S-ICD system, as well as patients who previously were implanted with an Emblem S-ICD system, have reassurance they can safely undergo MR scans while remaining protected from cardiac arrest,” says Kenneth Stein, MD, chief medical officer of rhythm management.
For more information about these systems, visit Boston Scientific.
